Trial Profile

Phase IIa trial of ISC-hpNSC in patients with Parkinson's disease

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 16 Mar 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ISC-hpNSC (Primary)
Indications Parkinson's disease
Focus Therapeutic Use
Sponsors International Stem Cell Corporation

Most Recent Events

16 Mar 2016 New trial record
14 Apr 2015 According to a media release, International Stem Cell Corporation has submitted a CTX application to the Australian regulatory authorities and plans to initiate the trial within the next few months.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com